Skip to content

Improving the understanding of the anatomy and lymph flow in the central lymphatic system in patients with Noonan Syndrome Spectrum Disorder

Improving the understanding of the anatomy and lymph flow in the central lymphatic system in patients with Noonan Syndrome Spectrum Disorder - The lymphatic phenotype in Noonan Syndrome Spectrum Disorder

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON53172
Enrollment
15
Registered
2023-11-29
Start date
2024-03-27
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Central conducting lymphatic anomalies in patients with Noonan Syndrome Spectrum Disorder

Interventions

None listed

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Noonan Syndrome confirmed by genetic test with a class 4 or 5 pathogenic variant according to ClinVar - 18 years and older (no restriction for sex) - Willing and able to have MR lymphangiography scanning in the Radboudumc - Oral and written informed consent - None of the exclusion criteria

Exclusion criteria

Exclusion criteria: - unsuitable for MRI (e.g. metallic objects in the body, severe claustrophobia) - A history of symptoms related to lymphatic disease - pregnancy - renal insufficiency - liver cirrhosis - History of surgery related to cardiovascular disease with hemodynamic consequence - Other genetic diseases

Design outcomes

Primary

MeasureTime frame
Anatomical categorizing and measurements of both the thoracic duct and the cisterna chyli (conducted in the coronal plane on whichever MR sequence offers the best visualization of these structures). Measurements consist of the maximal diameter of the thoracic duct and the diameter at the level of the diaphragm, and the width and length of the cisterna chyli. Lymph flow velocity will be determined on the dynamic MR lymphangiography by measuring the distance of contrast movement covered over time in cm/min.

Secondary

MeasureTime frame
Patient characteristics such as: age, gender, body height and weight, clinical history and genetic background.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)